Sequencing of systemic therapies in advanced NSCLC with MET exon 14 skipping mutation: A multicenter experience.

被引：3
|
作者：
Lau, Sally C. M.
Perdrizet, Kirstin
Mata, Danilo Giffoni de Mello Morais
Fung, Andrea S.
Liu, Geoffrey
Bradbury, Penelope Ann
Shepherd, Frances A.
Sacher, Adrian G.
Sheffield, Brandon
Hwang, David
Tsao, Ming Sound
Cheng, Susanna Y.
Cheema, Parneet
Leighl, Natasha B.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[4] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[5] Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada
[7] William Osler Hlth Ctr, Brampton, ON, Canada
[8] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[9] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[10] Univ Toronto, William Osler Hlth Syst, Toronto, ON, Canada
[11] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21123
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21123
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Lung adenocarcinoma with MET exon 14 skipping mutation; clinicopathological characteristics and immunohistochemical MET expression
    Motoi, Noriko
    Sunami, Kuniko
    Ohe, Yuichiro
    Watanabe, Shun-ichi
    Kohno, Takashi
    MODERN PATHOLOGY, 2018, 31 : 742 - 742
  • [42] Clinical and molecular Characterization of NSCLCs with MET exon 14 skipping mutation coexist MET amplification
    Tian, Huimin
    Tan, Yuan
    Zhang, Qin
    Duan, Qianqian
    Sun, Tingting
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapy
    Griesinger, F.
    Felip, E.
    Smit, E. F.
    Veillon, R.
    Raskin, J.
    Thomas, M.
    Conte, P.
    Kowalski, D.
    Paz-Ares, L.
    Garcia Ledo, G.
    de Marinis, F.
    Scherz, A.
    Berghoff, K.
    Bruns, R.
    Otto, G.
    Paik, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S40 - S41
  • [44] Characteristics and clinical courses in a monocentric NSCLC cohort with MET exon 14 skipping mutations
    Rafflenbeul, G.
    Lips, C.
    Blum, T. G.
    Hollmann, M.
    Kollmeier, J.
    Misch, D.
    Stephan-Falkenau, S.
    Streubel, A.
    Thiel, S.
    Mairinger, T.
    Bauer, T.
    Lips, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [45] MET Exon 14 Skipping Mutations and. Gene Amplifications Are Not Simultaneous Events in NSCLC
    Clave, Sergi
    Dalmases, Alba
    Longarem, Raquel
    Pijuan, Lara
    Casadevall, David
    Taus, Alvaro
    Albane, Joan
    Espinet, Blanca
    Arriola, Edurne
    Bellosillo, Beatriz
    Salido, Marta
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S516 - S517
  • [46] Tepotinib in Patients with Advanced NSCLC with MET Exon 14 (METex14) Skipping: Overall Efficacy Results from VISION Cohort A
    Mazieres, J.
    Paik, P.
    Felip, E.
    Veillon, R.
    Sakai, H.
    Cortot, A.
    Viteri, S.
    Garassino, M.
    Van Meerbeeck, J.
    Raskin, J.
    Thomas, M.
    Morise, M.
    Cho, B. C.
    Conte, P.
    Bruns, R.
    Demuth, T.
    Schumacher, K. M.
    Le, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S5 - S5
  • [47] Tepotinib in Patients with MET exon 14 (METex14) Skipping Advanced NSCLC: Updated Efficacy Results from VISION Cohort A
    Paik, P.
    Sakai, H.
    Felip, E.
    Veillon, R.
    Garassino, M. C.
    Raskin, J.
    Viteri, S.
    Mazieres, J.
    Cortot, A.
    Smit, E.
    Thomas, M.
    Cho, B. C.
    Conte, P.
    Yang, J. C.
    Morise, M.
    Chen, Y.
    Park, K.
    Gottfried, M.
    Britschgi, C.
    Bruns, R.
    Otto, G.
    Johne, A.
    Le, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S174 - S174
  • [48] The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC
    Liu, Si-Yang
    Gou, Lan-Ying
    Li, An-Na
    Lou, Na-Na
    Gao, Hong-Fei
    Su, Jian
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Shao, Yang
    Dong, Zhong-Yi
    Zhou, Qing
    Zhong, Wen-Zhao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (09) : 1503 - 1510
  • [49] Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A
    Sakai, Hiroshi
    Morise, Masahiro
    Felip, Enriqueta
    Veillon, Remi
    Garassino, Marina Chiara
    Raskin, Jo
    Viteri, Santiago
    Mazieres, Julien
    Cortot, Alexis B.
    Smit, Egbert
    Thomas, Michael
    Cho, Byoung Chul
    Conte, Pierfranco
    Yang, James Chih-Hsin
    Chen, Yuh-Min
    Park, Keunchil
    Gottfried, Maya
    Britschgi, Christian
    Le, Xiuning
    Paik, Paul
    ANNALS OF ONCOLOGY, 2021, 32 : S290 - S290
  • [50] Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience
    Cui Wanyuan
    Brown, Nick
    Brown, Victoria
    Bulusu, Ramesh
    Denton, Arshi
    Evans, Joanne
    Forster, Martin
    Papadatos-Pastos, Dionysis
    Pellegrino, Loredana
    Walsh, Nessa
    Bruns, Rolf
    Otto, Gordon
    Paik, Paul
    LUNG CANCER, 2022, 165 : S38 - S39
12345